Aryl hydrocarbon receptor nuclear translocator (ARNT; the loss-of-ARNT could increase HDAC levels) is up-regulated in skin lesions of AD patients compared to normal participants (Robertson et al., 2012; Kim et al., 2014; Hong et al., 2016). The gene discussed is HDAC9; the disease is Alzheimer disease.